Trade LXRX

Lexicon Pharmaceuticals, Inc.

-

00:00:00

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; and LX9211, which is in Phase II clinical development for the treatment of neuropathic pain. The company has strategic collaboration and license agreements with Bristol-Myers Squibb Company, and Genentech, Inc. Lexicon Pharmaceuticals, Inc. was incorporated in 1995 and is headquartered in The Woodlands, Texas.
Read More

LXRX
Trading Specifications

Digits

3

Point

0.001

Spread

floating

Contract Size

1

Volume Min

1

Volume Max

10,000

Volume Step

1

Swap Long (Points)

-0.630

Swap Short (Points)

-0.370
Available on
MT5, TV, cTrader
Last update at February 22, 21:09 GMT+2
*Data Source: MT5 Server Prime Account Pricing

1D Change

-2.865%

Why BlackBull Markets?

26k+

Tradable Assets

1:500

Leverage up to

Regulated

Multi-Regulated

24/7

Customer Support

$0

No Minimum Deposit

Margin Calculator

Calculation Results

Current Price

2.34

Required Margin

Converted Currency

Required Margin

Account Based Currency

Join Now